IMPROVING COVID-19 VACCINATION UPTAKE IN HIV POSITIVE PREGNANT WOMEN IN NIGERIA

提高尼日利亚 HIV 阳性孕妇的 COVID-19 疫苗接种率

基本信息

  • 批准号:
    10619475
  • 负责人:
  • 金额:
    $ 14.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

A. Project Summary/Abstract With the current global devastation and loss of lives, livelihood, and share suffering as a result of the COVID-19 pandemic, especially with the weak health care systems and limited resources in Africa, there is need to conduct research that will provide valuable information on treatment and prevention options and to understand the peculiarities of different populations as they respond. The effective COVID-19 vaccines have been largely instrumental to success in fighting the pandemic in the last 18 months. While most countries in the developed world have vaccinated over 70% of their population, only 21 African countries have fully vaccinated between 10% and 19% of their populations. Nigeria has only vaccinated 7.2% of its adult population and boosted only 0.4% and there is currently no data of vaccination in pregnant women or HIV infected persons. Even with the improved access of vaccines to Africa, vaccine hesitancy continues to limit the ability to improve vaccine coverage in these countries. Our ongoing NIH funded BEAMING grant (5U01HD094658) situated at a tertiary hospital where we have conducted research for over 20 years and including two prospective natural history birth cohort studies in HIV is uniquely placed to rapidly provide information for the first time from this part of the world that is this vulnerable population. This supplemental submission builds on the BEAMING experience and infrastructure to address research questions of great public health importance on social and culture norms that could explain vaccine hesitancy in this vulnerable population. We plan to use the information to develop culturally and socially acceptable educational materials and sessions that target drivers of vaccine hesitancy in HIV pregnant women and their matched uninfected pregnant controls in Nigeria, with the objective of re-shaping policies and strategies towards improved COVID-19 vaccines uptake in preparation for other waves of SARS COV-2 or future pandemics through three specific aims. Aim 1 will document social and cultural reasons for COVID-19 vaccine hesitancy among pregnant women in Nigeria and whether HIV infection creates an additional layer of burden. Aim 2 will develop strategies and educational materials to improve COVID-19 vaccine hesitancy and coverage in this population based on responses obtained from Aim 1. Aim 3 will document for the presence of anti- SARS-CoV-2 antibodies in infected pregnant women with or without HIV-1 infection; and if possible, the presence of anti- SARS-CoV-2 passively transferred antibodies in their infants.
A.项目摘要/摘要 在当前的全球破坏和生命、生计和分担痛苦的情况下, 新冠肺炎大流行,特别是在卫生保健系统薄弱和资源有限的情况下 在非洲,需要进行研究,提供关于治疗和治疗的有价值的信息 预防方案,并在应对时了解不同人群的特点。 有效的新冠肺炎疫苗在很大程度上有助于成功抗击 在过去的18个月里发生了大流行。虽然发达国家的大多数国家都接种了疫苗 超过70%的人口,只有21个非洲国家完全接种了10%到10%的疫苗 占其人口的19%。尼日利亚只为7.2%的成年人口接种了疫苗,并提高了 只有0.4%,目前没有孕妇或感染艾滋病毒的妇女接种疫苗的数据 人。即使疫苗进入非洲的机会有所改善,疫苗的犹豫不决仍然是有限的 提高这些国家疫苗覆盖率的能力。我们正在进行的由美国国立卫生研究院资助的 Grant(5U01HD094658)位于我们进行研究的一家三级医院 20多年来,包括两项关于艾滋病毒的前瞻性自然史出生队列研究 独一无二的位置,第一次快速提供来自世界这一地区的信息 这就是这些脆弱的人群。这份补充提交的材料建立在 解决具有重大公共卫生重要性的研究问题的经验和基础设施 关于社会和文化规范,这可以解释疫苗在这一脆弱人群中的犹豫不决。 我们计划利用这些信息来发展文化和社会可接受的教育 针对HIV孕妇和他们的疫苗迟疑的驱动因素的材料和课程 在尼日利亚匹配未感染的孕妇对照,目标是重新制定政策和 为应对其他SARS浪潮而提高新冠肺炎疫苗接种率的策略 CoV-2或未来的大流行通过三个具体目标。目标1将记录社会和文化 尼日利亚孕妇对新冠肺炎疫苗犹豫不决的原因以及艾滋病毒 感染造成了额外的负担。目标2将制定战略和教育 改善新冠肺炎疫苗在这一人群中的迟疑性和覆盖率的材料 从AIM 1获得的答复。AIM 3将记录抗SARS-CoV-2的存在 感染HIV-1或不感染HIV-1的孕妇的抗体;如有可能, 婴儿中存在抗SARS-CoV-2被动转移抗体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alash'le G. Abimiku其他文献

Alash'le G. Abimiku的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alash'le G. Abimiku', 18)}}的其他基金

Geo-enabled detect and respond system for antimalarial resistance in Ghana: GDRS - Ghana
加纳的抗疟药耐药性地理检测和响应系统:GDRS - 加纳
  • 批准号:
    10713339
  • 财政年份:
    2023
  • 资助金额:
    $ 14.22万
  • 项目类别:
Expanding the pool of Independent Investigators in Implementation Science in Nigeria throug h HIV research training (EXPAND)
通过艾滋病毒研究培训扩大尼日利亚实施科学领域的独立研究者队伍 (EXPAND)
  • 批准号:
    10596166
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
Expanding the pool of Independent Investigators in Implementation Science in Nigeria throug h HIV research training (EXPAND)
通过艾滋病毒研究培训扩大尼日利亚实施科学领域的独立研究者队伍 (EXPAND)
  • 批准号:
    10872335
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
Breast Milk Microbiota Influence on Infant Immunity and Growth (BEAMING) ADMINISTRATIVE SUPPLEMENT
母乳微生物群对婴儿免疫和生长的影响 (BEAMING) 行政补充材料
  • 批准号:
    10631019
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
Expanding the pool of Independent Investigators in Implementation Science in Nigeria throug h HIV research training (EXPAND)
通过艾滋病毒研究培训扩大尼日利亚实施科学领域的独立研究者队伍 (EXPAND)
  • 批准号:
    10472879
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
Institute of Human Virology H3Africa Biorepository (I-HAB) ADMIN SUPPLEMENT
人类病毒学研究所 H3Africa 生物样本库 (I-HAB) 管理补充
  • 批准号:
    10631024
  • 财政年份:
    2022
  • 资助金额:
    $ 14.22万
  • 项目类别:
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
数据流在非洲感染动态通报中的作用 - INFORM Africa
  • 批准号:
    10490316
  • 财政年份:
    2021
  • 资助金额:
    $ 14.22万
  • 项目类别:
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
数据流在非洲感染动态通报中的作用 - INFORM Africa
  • 批准号:
    10669758
  • 财政年份:
    2021
  • 资助金额:
    $ 14.22万
  • 项目类别:
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
数据流在非洲感染动态通报中的作用 - INFORM Africa
  • 批准号:
    10312887
  • 财政年份:
    2021
  • 资助金额:
    $ 14.22万
  • 项目类别:
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
数据流在非洲感染动态通报中的作用 - INFORM Africa
  • 批准号:
    10672628
  • 财政年份:
    2021
  • 资助金额:
    $ 14.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了